1 | excluded | 6,939 |
2 | unevaluable | 16 |
3 | re-calculated | 7 |
4 | sobar | 5 |
5 | included.data | 4 |
6 | meta-analysable | 4 |
7 | redrawn | 4 |
8 | reported.the | 4 |
9 | 3-years-old | 3 |
10 | assessed.there | 3 |
11 | igg-negative | 3 |
12 | pyrexial | 3 |
13 | rdt-positive | 3 |
14 | re-transplanted | 3 |
15 | sacrified | 3 |
16 | small.three | 3 |
17 | ≤0.5°c | 3 |
18 | back-calculated | 2 |
19 | bully-victims | 2 |
20 | co-modelled | 2 |
21 | content-analysed | 2 |
22 | cross-titrated | 2 |
23 | infringed | 2 |
24 | lymphocytotoxicity | 2 |
25 | mensurated | 2 |
26 | non-cancer-specific | 2 |
27 | noncoincident | 2 |
28 | participant-initiated | 2 |
29 | recatheterised | 2 |
30 | recemented | 2 |
31 | rehospitalised | 2 |
32 | textually | 2 |
33 | unviable | 2 |
34 | will-power | 2 |
35 | 'hospital-acquired | 1 |
36 | 0.020-1.7 | 1 |
37 | 0.22±0.06 | 1 |
38 | 0.34±0.08 | 1 |
39 | 0.68/0.60 | 1 |
40 | 0.93/0.59 | 1 |
41 | 1.00/0.51 | 1 |
42 | 1960-73 | 1 |
43 | 1:4.8:1.3:2.2 | 1 |
44 | 2.00-3.01 | 1 |
45 | 2.27:1 | 1 |
46 | 2140€ | 1 |
47 | 39.5kda | 1 |
48 | 5,322 | 1 |
49 | 66.5mm/1h | 1 |
50 | 9.24±7.03 | 1 |
51 | a376g/g202a | 1 |
52 | abacteruric | 1 |
53 | acquined | 1 |
54 | acupuncture-naive | 1 |
55 | ad7b | 1 |
56 | aggrigated | 1 |
57 | analyzed-separately | 1 |
58 | aspermic | 1 |
59 | budget-neutral | 1 |
60 | built.3 | 1 |
61 | capsule-free | 1 |
62 | cephalothin-sensitive | 1 |
63 | co-monitored | 1 |
64 | co-supplied | 1 |
65 | collectd | 1 |
66 | collected.they | 1 |
67 | computered | 1 |
68 | considered.studies | 1 |
69 | cxfv-positive | 1 |
70 | descriptive/observational | 1 |
71 | detectioned | 1 |
72 | discret | 1 |
73 | documentation-related | 1 |
74 | eia-negative/sra-positive | 1 |
75 | endotoxin-positive | 1 |
76 | enterovirus-positive | 1 |
77 | erythromicin-sensitive | 1 |
78 | eucortisolemic | 1 |
79 | exhortation | 1 |
80 | finished/polished | 1 |
81 | flutamide-sensitive | 1 |
82 | found.future | 1 |
83 | functionallydependent | 1 |
84 | fungal-culture-negative | 1 |
85 | fv-seronegative | 1 |
86 | hand-traced | 1 |
87 | hbsab-negative | 1 |
88 | heteregeneous | 1 |
89 | hp-seropositive | 1 |
90 | hypermagnesuric | 1 |
91 | identfied | 1 |
92 | implanted/patient | 1 |
93 | included.1 | 1 |
94 | included.studies | 1 |
95 | inconclusive.there | 1 |
96 | intercompared | 1 |
97 | inusual | 1 |
98 | investigated.a | 1 |
99 | investigator-identified | 1 |
100 | isolation-negative | 1 |
101 | measured.2 | 1 |
102 | measured/recorded | 1 |
103 | misclassified/missed | 1 |
104 | multi-traumatized | 1 |
105 | multifocal/infiltrative/recurrent | 1 |
106 | multisensitized | 1 |
107 | nads | 1 |
108 | nagged | 1 |
109 | naltrexone-reversible | 1 |
110 | negative/negative | 1 |
111 | non-africans | 1 |
112 | non-groupable | 1 |
113 | non-predictors | 1 |
114 | non-sudep | 1 |
115 | nonhyperfiltering | 1 |
116 | not-nash | 1 |
117 | nr1i3- | 1 |
118 | offloaded | 1 |
119 | ofloxacin-susceptible | 1 |
120 | ohserved | 1 |
121 | overappreciated | 1 |
122 | pcr+ | 1 |
123 | post-operated | 1 |
124 | pregnant.there | 1 |
125 | primis | 1 |
126 | randomized/completed | 1 |
127 | rct-supported | 1 |
128 | re-lavaged | 1 |
129 | re-sequenced | 1 |
130 | recored | 1 |
131 | redused | 1 |
132 | refashioned | 1 |
133 | repaired/replaced | 1 |
134 | retrived | 1 |
135 | reviwed | 1 |
136 | selfconscious | 1 |
137 | selfishly | 1 |
138 | shortlived | 1 |
139 | sign/symptom-free | 1 |
140 | silver-stained | 1 |
141 | skin/s.c | 1 |
142 | sleeted | 1 |
143 | sm-/sb- | 1 |
144 | spss7.5 | 1 |
145 | stanched | 1 |
146 | stud-ied | 1 |
147 | sub-analyzed | 1 |
148 | sub-minimal | 1 |
149 | subemployed | 1 |
150 | succed | 1 |
151 | tacrine-related | 1 |
152 | taken-up | 1 |
153 | tested.1 | 1 |
154 | triple-rooted | 1 |
155 | uetg-positive | 1 |
156 | un-rewarding | 1 |
157 | unambulatory | 1 |
158 | unamplifiable | 1 |
159 | under-applied | 1 |
160 | underdosages | 1 |
161 | ungradable | 1 |
162 | university-administered | 1 |
163 | value-consistent | 1 |
164 | well-discriminated | 1 |
165 | wt1-positive | 1 |
166 | znal-ldhs | 1 |
167 | €7,079 | 1 |
168 | €9476 | 1 |
169 | ≥0.9941 | 1 |
1 | 'hospital-acquired | 1 |
2 | 0.020-1.7 | 1 |
3 | 0.22±0.06 | 1 |
4 | 0.34±0.08 | 1 |
5 | 0.68/0.60 | 1 |
6 | 0.93/0.59 | 1 |
7 | 1.00/0.51 | 1 |
8 | 1960-73 | 1 |
9 | 1:4.8:1.3:2.2 | 1 |
10 | 2.00-3.01 | 1 |
11 | 2.27:1 | 1 |
12 | 2140€ | 1 |
13 | 3-years-old | 3 |
14 | 39.5kda | 1 |
15 | 5,322 | 1 |
16 | 66.5mm/1h | 1 |
17 | 9.24±7.03 | 1 |
18 | a376g/g202a | 1 |
19 | abacteruric | 1 |
20 | acquined | 1 |
21 | acupuncture-naive | 1 |
22 | ad7b | 1 |
23 | aggrigated | 1 |
24 | analyzed-separately | 1 |
25 | aspermic | 1 |
26 | assessed.there | 3 |
27 | back-calculated | 2 |
28 | budget-neutral | 1 |
29 | built.3 | 1 |
30 | bully-victims | 2 |
31 | capsule-free | 1 |
32 | cephalothin-sensitive | 1 |
33 | co-modelled | 2 |
34 | co-monitored | 1 |
35 | co-supplied | 1 |
36 | collectd | 1 |
37 | collected.they | 1 |
38 | computered | 1 |
39 | considered.studies | 1 |
40 | content-analysed | 2 |
41 | cross-titrated | 2 |
42 | cxfv-positive | 1 |
43 | descriptive/observational | 1 |
44 | detectioned | 1 |
45 | discret | 1 |
46 | documentation-related | 1 |
47 | eia-negative/sra-positive | 1 |
48 | endotoxin-positive | 1 |
49 | enterovirus-positive | 1 |
50 | erythromicin-sensitive | 1 |
51 | eucortisolemic | 1 |
52 | excluded | 6,939 |
53 | exhortation | 1 |
54 | finished/polished | 1 |
55 | flutamide-sensitive | 1 |
56 | found.future | 1 |
57 | functionallydependent | 1 |
58 | fungal-culture-negative | 1 |
59 | fv-seronegative | 1 |
60 | hand-traced | 1 |
61 | hbsab-negative | 1 |
62 | heteregeneous | 1 |
63 | hp-seropositive | 1 |
64 | hypermagnesuric | 1 |
65 | identfied | 1 |
66 | igg-negative | 3 |
67 | implanted/patient | 1 |
68 | included.1 | 1 |
69 | included.data | 4 |
70 | included.studies | 1 |
71 | inconclusive.there | 1 |
72 | infringed | 2 |
73 | intercompared | 1 |
74 | inusual | 1 |
75 | investigated.a | 1 |
76 | investigator-identified | 1 |
77 | isolation-negative | 1 |
78 | lymphocytotoxicity | 2 |
79 | measured.2 | 1 |
80 | measured/recorded | 1 |
81 | mensurated | 2 |
82 | meta-analysable | 4 |
83 | misclassified/missed | 1 |
84 | multi-traumatized | 1 |
85 | multifocal/infiltrative/recurrent | 1 |
86 | multisensitized | 1 |
87 | nads | 1 |
88 | nagged | 1 |
89 | naltrexone-reversible | 1 |
90 | negative/negative | 1 |
91 | non-africans | 1 |
92 | non-cancer-specific | 2 |
93 | non-groupable | 1 |
94 | non-predictors | 1 |
95 | non-sudep | 1 |
96 | noncoincident | 2 |
97 | nonhyperfiltering | 1 |
98 | not-nash | 1 |
99 | nr1i3- | 1 |
100 | offloaded | 1 |
101 | ofloxacin-susceptible | 1 |
102 | ohserved | 1 |
103 | overappreciated | 1 |
104 | participant-initiated | 2 |
105 | pcr+ | 1 |
106 | post-operated | 1 |
107 | pregnant.there | 1 |
108 | primis | 1 |
109 | pyrexial | 3 |
110 | randomized/completed | 1 |
111 | rct-supported | 1 |
112 | rdt-positive | 3 |
113 | re-calculated | 7 |
114 | re-lavaged | 1 |
115 | re-sequenced | 1 |
116 | re-transplanted | 3 |
117 | recatheterised | 2 |
118 | recemented | 2 |
119 | recored | 1 |
120 | redrawn | 4 |
121 | redused | 1 |
122 | refashioned | 1 |
123 | rehospitalised | 2 |
124 | repaired/replaced | 1 |
125 | reported.the | 4 |
126 | retrived | 1 |
127 | reviwed | 1 |
128 | sacrified | 3 |
129 | selfconscious | 1 |
130 | selfishly | 1 |
131 | shortlived | 1 |
132 | sign/symptom-free | 1 |
133 | silver-stained | 1 |
134 | skin/s.c | 1 |
135 | sleeted | 1 |
136 | sm-/sb- | 1 |
137 | small.three | 3 |
138 | sobar | 5 |
139 | spss7.5 | 1 |
140 | stanched | 1 |
141 | stud-ied | 1 |
142 | sub-analyzed | 1 |
143 | sub-minimal | 1 |
144 | subemployed | 1 |
145 | succed | 1 |
146 | tacrine-related | 1 |
147 | taken-up | 1 |
148 | tested.1 | 1 |
149 | textually | 2 |
150 | triple-rooted | 1 |
151 | uetg-positive | 1 |
152 | un-rewarding | 1 |
153 | unambulatory | 1 |
154 | unamplifiable | 1 |
155 | under-applied | 1 |
156 | underdosages | 1 |
157 | unevaluable | 16 |
158 | ungradable | 1 |
159 | university-administered | 1 |
160 | unviable | 2 |
161 | value-consistent | 1 |
162 | well-discriminated | 1 |
163 | will-power | 2 |
164 | wt1-positive | 1 |
165 | znal-ldhs | 1 |
166 | €7,079 | 1 |
167 | €9476 | 1 |
168 | ≤0.5°c | 3 |
169 | ≥0.9941 | 1 |
1 | pcr+ | 1 |
2 | nr1i3- | 1 |
3 | sm-/sb- | 1 |
4 | 0.68/0.60 | 1 |
5 | included.1 | 1 |
6 | tested.1 | 1 |
7 | 2.00-3.01 | 1 |
8 | ≥0.9941 | 1 |
9 | 1.00/0.51 | 1 |
10 | 2.27:1 | 1 |
11 | 1:4.8:1.3:2.2 | 1 |
12 | measured.2 | 1 |
13 | 5,322 | 1 |
14 | built.3 | 1 |
15 | 9.24±7.03 | 1 |
16 | 1960-73 | 1 |
17 | spss7.5 | 1 |
18 | 0.22±0.06 | 1 |
19 | €9476 | 1 |
20 | 0.020-1.7 | 1 |
21 | 0.34±0.08 | 1 |
22 | 0.93/0.59 | 1 |
23 | €7,079 | 1 |
24 | investigated.a | 1 |
25 | a376g/g202a | 1 |
26 | 39.5kda | 1 |
27 | included.data | 4 |
28 | ad7b | 1 |
29 | skin/s.c | 1 |
30 | non-cancer-specific | 2 |
31 | eucortisolemic | 1 |
32 | aspermic | 1 |
33 | abacteruric | 1 |
34 | hypermagnesuric | 1 |
35 | ≤0.5°c | 3 |
36 | repaired/replaced | 1 |
37 | hand-traced | 1 |
38 | succed | 1 |
39 | re-sequenced | 1 |
40 | offloaded | 1 |
41 | measured/recorded | 1 |
42 | excluded | 6,939 |
43 | re-lavaged | 1 |
44 | nagged | 1 |
45 | infringed | 2 |
46 | stanched | 1 |
47 | finished/polished | 1 |
48 | stud-ied | 1 |
49 | sacrified | 3 |
50 | investigator-identified | 1 |
51 | identfied | 1 |
52 | under-applied | 1 |
53 | co-supplied | 1 |
54 | co-modelled | 2 |
55 | silver-stained | 1 |
56 | acquined | 1 |
57 | refashioned | 1 |
58 | detectioned | 1 |
59 | intercompared | 1 |
60 | university-administered | 1 |
61 | computered | 1 |
62 | 'hospital-acquired | 1 |
63 | recored | 1 |
64 | co-monitored | 1 |
65 | rehospitalised | 2 |
66 | recatheterised | 2 |
67 | misclassified/missed | 1 |
68 | redused | 1 |
69 | content-analysed | 2 |
70 | aggrigated | 1 |
71 | overappreciated | 1 |
72 | participant-initiated | 2 |
73 | tacrine-related | 1 |
74 | documentation-related | 1 |
75 | re-calculated | 7 |
76 | back-calculated | 2 |
77 | well-discriminated | 1 |
78 | post-operated | 1 |
79 | cross-titrated | 2 |
80 | mensurated | 2 |
81 | sleeted | 1 |
82 | randomized/completed | 1 |
83 | re-transplanted | 3 |
84 | recemented | 2 |
85 | triple-rooted | 1 |
86 | rct-supported | 1 |
87 | shortlived | 1 |
88 | retrived | 1 |
89 | ohserved | 1 |
90 | reviwed | 1 |
91 | subemployed | 1 |
92 | multi-traumatized | 1 |
93 | multisensitized | 1 |
94 | sub-analyzed | 1 |
95 | 3-years-old | 3 |
96 | collectd | 1 |
97 | capsule-free | 1 |
98 | sign/symptom-free | 1 |
99 | small.three | 3 |
100 | reported.the | 4 |
101 | ungradable | 1 |
102 | unamplifiable | 1 |
103 | unviable | 2 |
104 | non-groupable | 1 |
105 | meta-analysable | 4 |
106 | unevaluable | 16 |
107 | naltrexone-reversible | 1 |
108 | ofloxacin-susceptible | 1 |
109 | assessed.there | 3 |
110 | inconclusive.there | 1 |
111 | pregnant.there | 1 |
112 | found.future | 1 |
113 | acupuncture-naive | 1 |
114 | hbsab-negative | 1 |
115 | fungal-culture-negative | 1 |
116 | igg-negative | 3 |
117 | isolation-negative | 1 |
118 | negative/negative | 1 |
119 | fv-seronegative | 1 |
120 | flutamide-sensitive | 1 |
121 | erythromicin-sensitive | 1 |
122 | cephalothin-sensitive | 1 |
123 | wt1-positive | 1 |
124 | eia-negative/sra-positive | 1 |
125 | uetg-positive | 1 |
126 | endotoxin-positive | 1 |
127 | enterovirus-positive | 1 |
128 | rdt-positive | 3 |
129 | cxfv-positive | 1 |
130 | hp-seropositive | 1 |
131 | un-rewarding | 1 |
132 | nonhyperfiltering | 1 |
133 | 66.5mm/1h | 1 |
134 | not-nash | 1 |
135 | pyrexial | 3 |
136 | sub-minimal | 1 |
137 | descriptive/observational | 1 |
138 | budget-neutral | 1 |
139 | inusual | 1 |
140 | exhortation | 1 |
141 | redrawn | 4 |
142 | non-sudep | 1 |
143 | taken-up | 1 |
144 | sobar | 5 |
145 | will-power | 2 |
146 | nads | 1 |
147 | underdosages | 1 |
148 | included.studies | 1 |
149 | considered.studies | 1 |
150 | znal-ldhs | 1 |
151 | primis | 1 |
152 | bully-victims | 2 |
153 | non-africans | 1 |
154 | non-predictors | 1 |
155 | heteregeneous | 1 |
156 | selfconscious | 1 |
157 | discret | 1 |
158 | noncoincident | 2 |
159 | functionallydependent | 1 |
160 | implanted/patient | 1 |
161 | multifocal/infiltrative/recurrent | 1 |
162 | value-consistent | 1 |
163 | collected.they | 1 |
164 | analyzed-separately | 1 |
165 | selfishly | 1 |
166 | textually | 2 |
167 | unambulatory | 1 |
168 | lymphocytotoxicity | 2 |
169 | 2140€ | 1 |